Analyst action, April 13

Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.

Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (10% upside) price target at SVB Leerink.

BridgeBio Pharma (NASDAQ:BBIO) initiated with Buy rating and $50 (76% upside) at H.C. Wainwright.

Cerner (NASDAQ:CERN) initiated with Outperform rating and $78 (14% upside) price target at Leerink.

Change Healthcare (NASDAQ:CHNG) resumed with Outperform rating and $13 (24% upside) price target at Leerink. Shares down 5% premarket.

Health Catalyst (NASDAQ:HCAT) initiated with Outperform rating and $31 (24% upside) price target at Leerink.

HealthEquity (NASDAQ:HQY) initiated with Market Perform rating and $53 (8% upside) price target at Leerink.

HMS Holdings (NASDAQ:HMSY) resumed with Outperform rating and $31 (16% upside) price target at Leerink.

Inovalon Holdings (NASDAQ:INOV) initiated with Outperform rating and $21 (27% upside) price target at Leerink.

Livongo Health (NASDAQ:LVGO) resumed with Outperform rating and $49 (47% upside) price target at Leerink. Shares up 2% premarket.

Neoleukin Therapeutics (NASDAQ:NLTX) initiated with Buy rating and $22 (94% upside) price target at Wainwright.

NextGen Healthcare (NASDAQ:NXGN) initiated with Market Perform rating and $12 (12% upside) price target at Leerink.

Phreesia (NYSE:PHR) initiated with Outperform rating and $24 (22% upside) price target at Leerink.

Premier (NASDAQ:PINC) initiated with Outperform rating and $42 (29% upside) price target at Leerink.

RAPT Therapeutics (NASDAQ:RAPT) initiated with Buy rating and $38 (121% upside) price target at Roth Capital.

Tabula Rasa HealthCare (NASDAQ:TRHC) initiated with Outperform rating and $65 (22% upside) price target at Leerink.

Teladoc (NYSE:TDOC) resumed with Outperform rating and $180 (22% upside) price target at Leerink.

Avanos Medical (NYSE:AVNS) upgraded to Equal Weight with a $30 (4% upside) price target at Barclays.

https://seekingalpha.com/news/3560052-leerink-rolls-out-lineup-of-bullish-calls-in-premarket-analyst-action